Ultragenyx Pharmaceutical and Fortress Biotech are seeking FDA approval for gene therapy candidates.
1 report, 1 independent
Updated Jul 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ultragenyx Pharmaceutical and Fortress Biotech are seeking FDA approval for gene therapy candidates.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ultragenyx Pharmaceutical
biopharmaceutical company based in Novato, California, United States
Nothing else this week.
-
Fortress Biotech
company
Related events
Coverage
Newest first; wire copies grouped- ZacksUltragenyx (RARE) Surges 5.1%: Is This an Indication of Further Gains? Ultragenyx RARE shares ended the last trading session 5.1% higher at $41.44. The jump came on an impressive volume with a higher